Zelnorm

Marketed by Novartis AG, Zelnorm is prescribed to help treat constipation in those suffering from irritable bowel syndrome, which is a functional bowel disorder. Zelnorm causes nerve cells to quicken the release of stools. Unfortunately, Zelnorm was taken off the market after it was associated with a number of cardiac problems.

In 2007, researched showed a link between Zelnorm and heart complications including angina, strokes and heart attacks. After influence from the FDA, Novartis took Zelnorm off the market in March 2007. Then, only a few months later, the FDA let Novartis market Zelnorm as an investigational drug, only to be given to people meeting specific criteria.

If you or a loved one has suffered cardiac problems after taking Zelnorm, contact a skilled attorney immediately.